F. Gervais

发表

The rcsB gene, a positive regulator of colanic acid biosynthesis in Escherichia coli, is also an activator of ftsZ expression

F. Gervais, P. Phoenix, G. Drapeau, 1992, Journal of bacteriology.

The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site

J. M. Lee, P. Branton, A. Veillette, 1993 .

Caspase-3 cleaves the formin-homology-domain-containing protein FHOD1 during apoptosis to generate a C-terminal fragment that is targeted to the nucleolus

D. Nicholson, Sophie Roy, F. Gervais, 2006, Apoptosis.

Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation

David Smith, G. Robertson, Daigen Xu, 1999, Cell.

Immunopharmacology and in fl ammation Anti-in fl ammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th 2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary in fl ammation

Raquel S. Sevilla, J. Klappenbach, Hyun-Hee Lee, 2014 .

Interactions of CD45-associated Protein with the Antigen Receptor Signaling Machinery in T-lymphocytes*

S. Latour, A. Veillette, F. Gervais, 1999, The Journal of Biological Chemistry.

Reconstitution of Interactions between Protein-tyrosine Phosphatase CD45 and Tyrosine-protein Kinase p56 lck in Nonlymphoid Cells*

A. Veillette, F. Gervais, 1997, The Journal of Biological Chemistry.

Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.

G. Gish, A. Veillette, R. Weil, 1993, Oncogene.

The unique amino-terminal domain of p56lck regulates interactions with tyrosine protein phosphatases in T lymphocytes

A. Veillette, F. Gervais, A. Veillette, 1995, Molecular and cellular biology.

Development and pharmacological validation of novel methods of B cell activation in rat whole blood.

P. Brandish, A. Hicks, F. Gervais, 2015, Journal of pharmacological and toxicological methods.

Characterizing Pharmacokinetic–Pharmacodynamic Relationships and Efficacy of PI3Kδ Inhibitors in Respiratory Models of TH2 and TH1 Inflammation

H. Houshyar, Hongshi Yu, S. Alves, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases.

M. Crackower, D. Denis, R. Stocco, 2011, Bioorganic & medicinal chemistry letters.

Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa

G. O'neill, M. Desrosiers, D. Wright, 2004 .

High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine.

M. Leppert, M. Scholand, P. Thibault, 2009, Analytical chemistry.

Huntingtin Interacting Protein 1 Induces Apoptosis via a Novel Caspase-dependent Death Effector Domain*

A. Hackam, L. Raymond, M. Hayden, 2000, The Journal of Biological Chemistry.

Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist

D. Slipetz, M. Crackower, D. Denis, 2011, Molecular Pharmacology.

The C3a receptor antagonist SB 290157 has agonist activity.

A. Therien, S. Kargman, G. O'neill, 2005, Immunology letters.

Azaindoles as potent CRTH2 receptor antagonists.

R. Stocco, Y. Leblanc, M. Hamel, 2011, Bioorganic & medicinal chemistry letters.

The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site

J. M. Lee, P. Branton, A. Veillette, 1993, Molecular and cellular biology.

Identification of a Potent and Selective Synthetic Agonist at the CRTH2 Receptor

D. Denis, G. O'neill, C. Beaulieu, 2005, Molecular Pharmacology.

New indole amide derivatives as potent CRTH2 receptor antagonists.

R. Stocco, Y. Leblanc, M. Hamel, 2011, Bioorganic & medicinal chemistry letters.

Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.

G. O'neill, K. Metters, F. Nantel, 2001, The Journal of allergy and clinical immunology.

Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists.

Yongxin Han, S. Kargman, R. Lobell, 2009, Bioorganic & medicinal chemistry letters.

Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi

A. Hackam, M. Hayden, B. Leavitt, 2002, Nature Cell Biology.

L. Matis, S. Nye, A. Veillette, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Caspases Cleave Focal Adhesion Kinase during Apoptosis to Generate a FRNK-like Polypeptide*

N. Thornberry, D. Nicholson, S. C. Ruffolo, 1998, The Journal of Biological Chemistry.

Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2

G. O'neill, D. Nicholson, K. Metters, 2002, British journal of pharmacology.

Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.

G. Robertson, M. Rigby, R. Zamboni, 1999, Cell.

Identification, cloning, and characterization of rcsF, a new regulator gene for exopolysaccharide synthesis that suppresses the division mutation ftsZ84 in Escherichia coli K-12

F. Gervais, G. Drapeau, G. R. Drapeau, 1992, Journal of bacteriology.

Identification of Distinct Plasma Biomarker Signatures in Patients with Rapid and Slow Declining Forms of COPD

M. Leppert, V. Devanarayan, M. Crackower, 2011, COPD.